CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Activity

46 hedge funds and large institutions have $14.9M invested in Cellectar Biosciences in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 5 reducing their positions, and 10 closing their positions.

Holders
46
Holders Change
+1
Holders Change %
+2.22%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
18
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.23M
2
ACM
2
ACT Capital Management
Pennsylvania
$259K
3
PAM
3
PVG Asset Management
Colorado
$230K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$472K
5
State Street
5
State Street
Massachusetts
$176K

Top Sellers

1
SCM
1
Sio Capital Management
New York
$0
2
SCM
2
Silverarc Capital Management
Massachusetts
$0
3
Two Sigma Investments
3
Two Sigma Investments
New York
$306K
4
Millennium Management
4
Millennium Management
New York
$0
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$417K
Name Market Value Shares Shares
Change 		Shares
Change %
FFA
51
First Foundation Advisors
California
– – -10,000 Closed
Barclays
52
Barclays
United Kingdom
– – -364 Closed
CFGS
53
Concourse Financial Group Securities
Alabama
– – – –
AWM
54
AllSquare Wealth Management
New York
$0 188 – –
RCA
55
Ranch Capital Advisors
Florida
$0 50 – –
Fidelity Investments
56
Fidelity Investments
Massachusetts
$0 1 +1 New
Bank of America
57
Bank of America
North Carolina
$0 22 +22 New
1 2
3